The Breast Cancer lab is working to further the understanding of development and progression of breast cancer, in order to improve clinical management of breast cancer patients, with the ultimate goal to improve outcome.  We focus on three areas of research: i) resistance to hormonal therapy, including further understanding of the estrogen receptor ii) development and progression of invasive lobular breast cancer (ILC), the second most common histological subtype of breast cancer, and iii) drivers of metastases in breast cancer.